Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Metabolism, diet and disease

Open Access Poster presentation

Improvement of chemotherapy induced colitis with serum-derived bovine immunoglobulin

Gerald L Klein12* and Eric M Weaver2

  • * Corresponding author: Gerald L Klein

Author Affiliations

1 Thomas J Long School of Pharmacy and Health Science at the University of the Pacific, USA

2 Entera Health, Inc., Cary, NC, 27511, USA

For all author emails, please log on.

BMC Proceedings 2012, 6(Suppl 3):P26  doi:10.1186/1753-6561-6-S3-P26

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/6/S3/P26


Published:1 June 2012

© 2012 Klein and Weaver; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background

Chemotherapy-induced diarrhea is a common problem, with pain, ulceration, bloating, vomiting and diarrhea occurring in about 40% of patients on a standard regimen and dose [1]. The pathophysiology of this problem is quite complex, involving multiple pathways including increases in pro-inflammatory mediators tumor necrosis factor- alpha (TNF-α) and interleukin-6 (lL-6) [2]. Serum-derived bovine immunoglobulin (SBI) has been used for years; first as a valued feed ingredient for weaned pigs where it has been shown to decrease mortality and morbidity and increase growth rates [3]; and then as a safe dietary supplement in humans [4]. In experimental animal models, SBI has been found to decrease both TNF -α and lL-6 in intestinal inflammation, and decrease intestinal permeability [5].

Case history

This patient is a white female, 54 years of age, who developed a renal cell carcinoma and an unrelated adenocarcinoma of the ovary. She underwent a nephrectomy, empiric lymph node dissection, omentectomy, and bilateral salpingo-oophrectomy. A 6-week course of carboplatin and paclitaxel was prescribed for the treatment of the carcinoma of the ovary. Consistent with previous reports, this treatment regimen induced abdominal pain, nausea, vomiting, and diarrhea; resulting in a 12 kilogram weight loss. With the physician’s approval, she began using 2 g of SBI b.i.d as a food supplement.

Results

After using SBI, this patient’s symptoms improved while she continued with chemotherapy. She gained 2.5 kilograms in the next 2 weeks, without side effects from SBI and was able to successfully complete her course of chemotherapy. SBI has previously been shown to decrease diarrhea and, recently, has been shown to decrease intestinal permeability [6].

Conclusions

SBI may have improved this patient’s gastrointestinal complaints and maintenance of body weight. Clinical and nonclinical studies are warranted to determine the efficacy of this food product in decreasing the side effects associated with chemotherapy treatment.

References

  1. Stringer AM, Gibson RJ, Logan RM, et al.: Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat.

    Exp Biol Med (Maywood) 2007, 232:96-106. OpenURL

  2. Bowen JM, Keefe DK: New pathways for alimentary mucositis.

    J Onc 2008, 1-7. OpenURL

  3. Peace RM, Campbell J, Polo J, et al.: Spray-dried porcine plasma influences intestinal barrier function, inflammation, and diarrhea in weaned pigs.

    J Nutr 2011, 141:1312-1317. OpenURL

  4. Lembcke J, Pearson J, Brown K: Acceptability, safety, and digestibility of spray-dried bovine serum added to diets of recovering malnourished children.

    J Pediatr Gastroenterol Nutr 1997, 25:381-384. OpenURL

  5. Moretó M, Pérez-Bosgue A: Dietary plasma proteins, the intestinal immune system, and the barrier functions of the intestinal mucosa.

    J Anim Sci 2009, 87:E92-E100. OpenURL

  6. Pérez-Bosgue A, Miro L, Polo J, et al.: Dietary plasma protein supplements prevent the release of mucosal proinflammatory mediators in intestinal inflammation in rats.

    J Nutr 2010, 140:25-30. OpenURL